Abstract | OBJECTIVES: METHODS: Altogether 30 Sprague-Dawley rats were randomized into three groups: control, the model group (HFHCD + saline) and the treatment group (HFHCD + YZH). Liver histological features and serum biochemical parameters were assessed by the end of the 16th week. RNA sequencing and protein mass spectrometry detection were performed. The genes and proteins expressed differentially were subjected to KEGG pathway enrichment analysis and included in a network-based regulatory model. RESULTS: CONCLUSION: YZH could alleviate NASH in HFHCD-fed rats by inhibiting lipogenesis, accelerating lipid β-oxidation, alleviating oxidative stress and relieving necroinflammation in the liver.
|
Authors | Jing Zeng, Xiao Lin Liu, Feng Zhi Xin, Ze Hua Zhao, You Lin Shao, Rui Xu Yang, Qin Pan, Jian Gao Fan |
Journal | Journal of digestive diseases
(J Dig Dis)
Vol. 21
Issue 3
Pg. 179-188
(Mar 2020)
ISSN: 1751-2980 [Electronic] Australia |
PMID | 31950587
(Publication Type: Journal Article)
|
Copyright | © 2020 The Authors. Journal of Digestive Diseases published by Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd. |
Chemical References |
- Cholesterol, Dietary
- Drugs, Chinese Herbal
- yin zhi huang
- Cholesterol
- Aspartate Aminotransferases
- Alanine Transaminase
|
Topics |
- Alanine Transaminase
(blood)
- Animals
- Aspartate Aminotransferases
(blood)
- Cholesterol
(blood)
- Cholesterol, Dietary
(adverse effects)
- Diet, High-Fat
(adverse effects)
- Disease Models, Animal
- Drugs, Chinese Herbal
(pharmacology)
- Inflammation
- Lipid Metabolism
(drug effects)
- Lipogenesis
(drug effects)
- Liver
(pathology)
- Male
- Non-alcoholic Fatty Liver Disease
(drug therapy, etiology)
- Oxidative Stress
(drug effects)
- Rats
- Rats, Sprague-Dawley
|